Pertussis: microbiology, disease, treatment, and prevention

PE Kilgore, AM Salim, MJ Zervos… - Clinical microbiology …, 2016 - Am Soc Microbiol
Pertussis is a severe respiratory infection caused by Bordetella pertussis, and in 2008,
pertussis was associated with an estimated 16 million cases and 195,000 deaths globally …

Hospital epidemiology and infection control in acute-care settings

ERM Sydnor, TM Perl - Clinical microbiology reviews, 2011 - Am Soc Microbiol
Health care-associated infections (HAIs) have become more common as medical care has
grown more complex and patients have become more complicated. HAIs are associated …

[HTML][HTML] Surveillance of vaccination coverage among adult populations—United States, 2018

PJ Lu - MMWR. Surveillance Summaries, 2021 - cdc.gov
Abstract Problem/Condition: Adults are at risk for illness, hospitalization, disability and, in
some cases, death from vaccine-preventable diseases, particularly influenza and …

[HTML][HTML] Prevention of pertussis, tetanus, and diphtheria with vaccines in the United States: recommendations of the Advisory Committee on Immunization Practices …

JL Liang - MMWR. Recommendations and reports, 2018 - cdc.gov
This report compiles and summarizes all recommendations from CDC's Advisory Committee
on Immunization Practices (ACIP) regarding prevention and control of tetanus, diphtheria …

Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial

FM Munoz, NH Bond, M Maccato, P Pinell, HA Hammill… - Jama, 2014 - jamanetwork.com
Importance Maternal immunization with tetanus toxoid, reduced diphtheria toxoid, and
acellular pertussis (Tdap) vaccine could prevent infant pertussis. Objective To evaluate the …

[HTML][HTML] Use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines: updated recommendations of the Advisory Committee on Immunization …

FP Havers - MMWR. Morbidity and mortality weekly report, 2020 - cdc.gov
Background Two Tdap vaccines are licensed for use in the United States. Boostrix
(GlaxoSmithKline) is approved for a single dose in persons aged≥ 10 years; Adacel (Sanofi …

Persistence of long-lived plasma cells and humoral immunity in individuals responding to CD19-directed CAR T-cell therapy

VG Bhoj, D Arhontoulis, G Wertheim… - Blood, The Journal …, 2016 - ashpublications.org
The mechanisms underlying the maintenance of long-lasting humoral immunity are not well
understood. Studies in mice indicate that plasma cells (PCs) can survive up to a lifetime …

Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States

SW Roush, TV Murphy… - Jama, 2007 - jamanetwork.com
ContextNational vaccine recommendations in the United States target an increasing number
of vaccine-preventable diseases for reduction, elimination, or eradication. ObjectiveTo …

Adverse reactions to vaccines practice parameter 2012 update

JM Kelso, MJ Greenhawt, JT Li, RA Nicklas… - Journal of Allergy and …, 2012 - jacionline.org
KELSO ET AL 27 allergy. Only for patients with a history of allergic reaction to influenza
vaccine itself is additional evaluation appropriate, including skin testing with the vaccine and …

Impact of the US maternal tetanus, diphtheria, and acellular pertussis vaccination program on preventing pertussis in infants< 2 months of age: a case-control …

TH Skoff, AE Blain, J Watt, K Scherzinger… - Clinical Infectious …, 2017 - academic.oup.com
Background Infants aged< 1 year are at highest risk for pertussis-related morbidity and
mortality. In 2012, Tdap (tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis) …